522
Views
63
CrossRef citations to date
0
Altmetric
Original Article

Hydrogel containing dexamethasone-loaded nanocapsules for cutaneous administration: preparation, characterization, and in vitro drug release study

, , , , , , , , , & show all
Pages 962-971 | Received 25 Sep 2009, Accepted 06 Jan 2010, Published online: 30 Jun 2010

References

  • Sahoo SK, Labhasetwar V. (2003). Nanotech approaches to delivery and imaging drug. Drug Discov Today, 8:1112–20.
  • Rawat M, Singh D, Saraf S, Saraf S. (2006). Nanocarriers: Promising vehicle for bioactive drugs. Biol Pharm Bull, 29:1790–8.
  • Devalapally H, Chakilam A, Amiji MM. (2007). Role of nanotechnology in pharmaceutical product development. J. Pharm Sci, 96:2547–65.
  • Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother, 58:168–72.
  • Guterres SS, Alves MP, Pohlmann AR. (2007). Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights, 2:147–57.
  • Ourique AF, Pohlmann AR, Guterres SS, Beck RCR. (2008). Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int J Pharm, 352:1–4.
  • Fontana MC, Coradini K, Guterres SS, Pohlmann AR, Beck RCR. (2009). Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: Influence of the nanostructured system. J Biomed Nanotechnol, 5:254–63.
  • Almeida JS, Jezur L, Fontana MC, Paese K, Silva CB, Pohlmann AR, . (2009). Oil-based nanoparticles containing alternative vegetable oils (grape seed oil and almond kernel oil): Preparation and characterization. Latin Am J Pharm, 28:165–72.
  • Alves MP, Scarrone AL, Santos M, Pohlmann AR, Guterres SS. (2007). Human skin penetration and distribution of nimesulide from hydrophilic gels containing nanocarriers. Int J Pharm, 341:215–20.
  • Paese K, Jäger A, Poletto FS, Fonseca EP, Rossi-Bergmann B, Pohlmann AR, . (2009). Semisolid formulation containing a nanoencapsulated sunscreen: Effectiveness, in vitro photostability and immune response. J Biomed Nanotechnol, 5:240–6.
  • Lademann J, Richter H, Teichmann A, Otberg N, Blume-peytavi U, Luengo J, . (2007). Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm, 66:159–64.
  • Jäger A, Stefani V, Guterres SS, Pohlmann AR. (2007). Physicol-chemical characterization of nanocapsule polymeric wall using fluorescent benvavole probes. Int J Pharm, 338:297–305.
  • Vauthier C, Bouchemal K. (2009). Preparation and manufacture of polymeric nanoparticles. Pharm Res, 25:1025–58.
  • Huynh NT, Passirani C, Saulnier P, Benoit JP. (2009). Lipid nanocapsules: A new platform for nanomedicine. Int J Pharm, 379:201–9.
  • Alvarez-Roman R, Baorre G, Guy RH, Fessi H. (2001). Biodegradable polymer nanocapsules containing a sunscreen agent: Preparation and photoprotection. Eur J Pharm Biopharm, 52:191–5.
  • Milão D, Knorst MT, Guterres SS. (2003). Hydrophilic gel containing nanocapsules of diclofenac: Development, stability study and physico-chemical characterization. Pharmazie, 58:325–9.
  • Miyazaki S, Takahashi A, Kubo W. (2003). Poly-n-butylcyanoacrilate (PNBCA) nanocapsules as a carrier for NSAID-s: In vitro release and in vivo skin penetration. J Pharm Sci, 6:240–5.
  • Jiménez MM, Pelletier J, Bobin MF, Martini MC. (2004). Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int J Pharm, 272:45–55.
  • Alves MP, Pohlmann AR, Guterres SS. (2005). Semisolid topical formulations containing nimesulide-loaded nanocapsules, nanospheres or nanoemulsion: Development and rheological characterization. Pharmazie, 60:900–4.
  • Weisse S, Kalimouttou S, Lahiani-Skiba M, Djedaini-Pilard F, Perly B, Skiba M. (2009). Investigations on topically applied vitamin A loaded amphiphilic cyclodextrin nanocapsules. J Nanosci Nanotechnol, 9:640–5.
  • Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch, RBröcker EB, Blaser K, . (2001). Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol, 108:839–46.
  • Valencia IC, Kerdel FA. (2003). In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick’s dermatology in general medicine. Topical Glucocorticoids New York: McGraw-Hill Professional, 2585–95.
  • Zampieri N, Corroppolo M, Zuin V, Bianchi S, Camoglio FS. (2007). Phimosis and topical steroids: New clinical findings. Pediatr Surg Int, 23:331–5.
  • Ahluwalia A. (1998). Topical glucocorticoids and the skin-mechanisms of action: An update. Mediators Inflamm, 7:183–93.
  • Wiedersberg S, Leopold CS, Guy RH. (2008). Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm, 68:453–66.
  • Kao JS, Fluhr JW, Man MQ, Fowler AJ, Hachem JP, Crumrine D, . (2003). Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis account for functional abnormalities. J Invest Dermatol, 120:456–64.
  • Friedrich RB, Fontana MC, Beck RCR, Pohlmann AR, Guterres SS. (2008). Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions. Quim Nova, 31:1131–6.
  • Fessi H, Puisieux F, Devissaguet JP. (1988). Procede de préparation dês systèmes coloïdaux d’une substance sous forme de nanocapsules. European Patent 0274961, Al.
  • Patra J, Sahoo MK, Panda BB. (2005). Salicylic acid triggers genotoxic adaptation to methyl mercuric chloride and ethyl methane sulfonate, but not to maleic hydrazide in root meristem cells of Allium cepa L. Mutat Res-Gen Toxicol Environ, 581:173–80.
  • Fachinetto JM, Ourique AF, Lubini G, Tedesco SB, Beck RCR. (2008). Tretinoin-loaded polymeric nanocapsules: Evaluation of the potential to improve the antiproliferative activities on Allium cepa root-tip compared to the free drug. Latin Am J Pharm, 27:668–73.
  • Fresno Contreras MJ, Ramirez Dieguez A, Jimenez Soriano MM. (2001). Rheological characterization of hydroalcoholic gels—15% ethanol—of Carbopol® Ultrez™ 10. Il Farmaco, 56:437–41.
  • Borghetti GS, Knorst MT. (2006). Desenvolvimento e avaliação da estabilidade física de loções O/A contendo filtros solares. Rev Bras Cienc Farm, 42:531–7.
  • Milan AL, Milão D, Souto AA, Corte TWF. (2007). Study of hydration skin by the cosmetics emulsions for xerosis and their stability by rheology. Rev Bras Cienc Farm, 43:649–57.
  • Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–57.
  • Quintanar-Guerrero D, Zorraquín-Cornejo BN, Ganem-Rondero A, Piñón-Segundo E, Nava-Arzaluz MG, Cornejo-Bravo JM. (2008). Controlled release of model substances from pH-sensitive hydrogels. J Mex Chem Soc, 52:272–8.
  • Vicentini VEP, Camparoto ML, Teixeira RO, Mantovani MS. (2001). Averrhoa carambola L., Syzygium cumini (L.) Skeels and Cissus sicoydes L.: Medicinal herbal tea effects on vegetal and animal test systems. Acta Sci, 23:593–8.
  • Teixeira RO, Camparoto ML, Mantovani MS, Vicentini VEP. (2003). Assessment of two medicinal plants, Psidium guajava L. and Achillea millefolium L. in in vivo assays. Genet Mol Biol, 26:551–5.
  • Camparoto ML, Teixeira RO, Mantovani MS, Vicentini VEP. (2002). Effects of Maytenus ilicifolia Mart. and Bauhinia candicans Benth infusions on onion root-tip and rat bone-marrow cells. Genet Mol Biol, 25:85–9.
  • Pinto-Alphandary H, Andremont A, Couvreur P. (2000). Targeted delivery of antibiotics using liposomes and nanoparticles: Research and applications. Int J Antimicrob Agents, 13:155–68.
  • Brannon-Peppas L, Blanchette JO. (2004). Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev, 56:1649–59.
  • Leiferman KM, Schroeter A, Kirschner MK, Spelsberg TC. (1983). Characterization of the glucocorticoid receptor in human skin. J Invest Dermatol, 81:355–60.
  • Kim MK, Choi SY. (2006). Evaluation of gender difference in skin type and pH. J Dermatol Sci, 41:153–6.
  • Barreiro-Iglesias R, Alvarez-Lorenzo C, Concheiro A. (2001). Incorporation of small quantities of surfactants as a way to improve the rheological and diffusional behavior of carbopol gels. J Control Release, 77:59–75.
  • Garg A, Aggarwal D, Garg S, Singla A. (2002). Spreading of semisolid formulations. Pharm Technol, 26:84–105.
  • Contreras MD, Sanchez R. (2002). Application of factorial design to the study of the flow behavior, spreadability, transparency of Carbopol ETD 2020® gel. Part II. Int J Pharm, 234:149–57.
  • Huuskonen J, Solo M, Taskinen J. (1997). Neural network modeling for estimation of the aqueous solubility of structurally related drugs. J Pharm Sci, 86:450–4.
  • Food and Drug Administration (FDA). U.S. Department of Health and Human Services. (1997). Guidance for industry: Nonsterile semisolid dosage forms. Scale-Up and postapproval changes: Chemistry, manufacturing, and controls; In vitro release testing and in vivo bioequivalence documentation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070930.pdf [accessed June 8, 2009].
  • Flynn GL, Shah PS, Tenjarla SN, Corbo M, DeMagistris D, Feldman TG, . (1999). Assessment of value and applications of in vitro testing of topical dermatological drug products. Pharm Res, 16:1325–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.